Literature DB >> 24930041

Penicillin susceptibility breakpoints for Streptococcus pneumoniae and their effect on susceptibility categorisation in Germany (1997-2013).

M Imöhl1, R R Reinert, P M Tulkens, M van der Linden.   

Abstract

Continuous nationwide surveillance of invasive pneumococcal disease (IPD) was conducted in Germany. From July 1, 1997, to June 30, 2013, data on penicillin susceptibility were available for 20,437 isolates. 2,790 of these isolates (13.7 %) originate from patients with meningitis and 17,647 isolates (86.3 %) are from non-meningitis cases. A slight decline in isolates susceptible at 0.06 and 0.12 μg/ml can be noticed over the years. Overall, 89.1 % of the isolates had minimum inhibitory concentrations (MICs) of ≤0.015 μg/ml. In 2012/2013, the first three isolates of Streptococcus pneumoniae with MICs of 8 μg/ml were found. The application of different guidelines with other MIC breakpoints for the interpretation of penicillin resistance leads to differences in susceptibility categorisation. According to the pre-2008 Clinical and Laboratory Standards Institute (CLSI) interpretive criteria, 5.3 % of isolates overall were intermediate and 1.4 % were resistant to penicillin. Application of the 2008-2014 CLSI interpretive criteria resulted in 7.6 % resistance among meningitis cases and 0.5 % intermediate resistance in non-meningitis cases. Referring to the 2009-2014 European Committee on Antimicrobial Susceptibility Testing (EUCAST) breakpoints, 7.6 % of the isolates in the meningitis group were resistant to penicillin. In the non-meningitis group, 6.1 % of the isolates were intermediate and 0.5 % were resistant. These differences should be kept in mind when surveillance studies on pneumococcal penicillin resistance are compared.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24930041     DOI: 10.1007/s10096-014-2174-z

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  25 in total

Review 1.  Pneumococcus: the first one hundred years.

Authors:  R Austrian
Journal:  Rev Infect Dis       Date:  1981 Mar-Apr

2.  Impact of new Clinical Laboratory Standards Institute Streptococcus pneumoniae penicillin susceptibility testing breakpoints on reported resistance changes over time.

Authors:  Robertino M Mera; Linda A Miller; Heather Amrine-Madsen; Daniel F Sahm
Journal:  Microb Drug Resist       Date:  2010-11-30       Impact factor: 3.431

3.  Trends in antimicrobial resistance in 1,968 invasive Streptococcus pneumoniae strains isolated in Spanish hospitals (2001 to 2003): decreasing penicillin resistance in children's isolates.

Authors:  Jesús Oteo; Edurne Lázaro; Francisco J de Abajo; Fernando Baquero; José Campos
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

Review 4.  Pneumococcal conjugate vaccines--a European perspective.

Authors:  Ralf René Reinert
Journal:  Int J Med Microbiol       Date:  2004-10       Impact factor: 3.473

5.  Increased prevalence of pediatric pneumococcal serotypes in elderly adults.

Authors:  Daniel R Feikin; Keith P Klugman; Richard R Facklam; Elizabeth R Zell; Anne Schuchat; Cynthia G Whitney
Journal:  Clin Infect Dis       Date:  2005-07-11       Impact factor: 9.079

6.  Historical changes in pneumococcal serogroup distribution: implications for the era of pneumococcal conjugate vaccines.

Authors:  Daniel R Feikin; Keith P Klugman
Journal:  Clin Infect Dis       Date:  2002-08-07       Impact factor: 9.079

7.  New susceptibility breakpoints in antimicrobial resistance rates of invasive pneumococcal strains.

Authors:  Paula Carolina Bejo Wolkers; Orlando Cesar Mantese; Alan de Paula; Vivieni Vieira Prado Almeida; Paula Augusta Dias Fogaça de Aguiar; Jackelline Rodrigues Alvares; Samanta Cristine Grassi Almeida; Maria Cristina de Cunto Brandileone
Journal:  J Pediatr (Rio J)       Date:  2009 Sep-Oct       Impact factor: 2.197

8.  Temporal Variations among Invasive Pneumococcal Disease Serotypes in Children and Adults in Germany (1992-2008).

Authors:  Matthias Imöhl; Ralf René Reinert; Mark van der Linden
Journal:  Int J Microbiol       Date:  2010-06-30

9.  Effects of new penicillin susceptibility breakpoints for Streptococcus pneumoniae--United States, 2006-2007.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2008-12-19       Impact factor: 17.586

10.  Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007.

Authors:  A Fenoll; J J Granizo; L Aguilar; M J Giménez; L Aragoneses-Fenoll; G Hanquet; J Casal; D Tarragó
Journal:  J Clin Microbiol       Date:  2009-02-18       Impact factor: 5.948

View more
  3 in total

1.  Use of Animal Models To Support Revising Meningococcal Breakpoints of β-Lactams.

Authors:  Nouria Belkacem; Eva Hong; Ana Antunes; Aude Terrade; Ala-Eddine Deghmane; Muhamed-Kheir Taha
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

2.  Antimicrobial Susceptibility Trends of Streptococcus pneumoniae by Age Groups Over Recent 10 Years in a Single Hospital in South Korea.

Authors:  Hyunjoo Oh; Sang Taek Heo; Misun Kim; Young Ree Kim; Jeong Rae Yoo
Journal:  Yonsei Med J       Date:  2021-04       Impact factor: 2.759

3.  Serotype Distribution and Antimicrobial Resistance of Streptococcus pneumoniae Isolates Causing Invasive and Noninvasive Pneumococcal Diseases in Korea from 2008 to 2014.

Authors:  Si Hyun Kim; Il Kwon Bae; Dongchul Park; Kyungmin Lee; Na Young Kim; Sae Am Song; Hye Ran Kim; Ga Won Jeon; Sang-Hwa Urm; Jeong Hwan Shin
Journal:  Biomed Res Int       Date:  2016-05-30       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.